Matches in Nanopublications for { ?s ?p "[TET2 mutations improve the ELN molecular-risk classification in primary CN-AML because of their adverse prognostic impact in an otherwise favorable-risk patient subset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP670464.RAsy45kRLZxBajBhn-bMHmDHKTkTfTj4heBNr4eNsBRsQ130_assertion description "[TET2 mutations improve the ELN molecular-risk classification in primary CN-AML because of their adverse prognostic impact in an otherwise favorable-risk patient subset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670464.RAsy45kRLZxBajBhn-bMHmDHKTkTfTj4heBNr4eNsBRsQ130_provenance.
- assertion description "[TET2 mutations improve the ELN molecular-risk classification in primary CN-AML because of their adverse prognostic impact in an otherwise favorable-risk patient subset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP914265.RACi_dfM3jkvoGXP4a0pN9bZrfSSub-tXglw5-DUPXpRg130_assertion description "[TET2 mutations improve the ELN molecular-risk classification in primary CN-AML because of their adverse prognostic impact in an otherwise favorable-risk patient subset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914265.RACi_dfM3jkvoGXP4a0pN9bZrfSSub-tXglw5-DUPXpRg130_provenance.
- NP874337.RApsND0Y2r8AQA4MV_iRt0SQ_lCVEVFG_WOStjTyMwHLY130_assertion description "[TET2 mutations improve the ELN molecular-risk classification in primary CN-AML because of their adverse prognostic impact in an otherwise favorable-risk patient subset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874337.RApsND0Y2r8AQA4MV_iRt0SQ_lCVEVFG_WOStjTyMwHLY130_provenance.